Caption Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Caption Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,000	Closed	-$2.32M	–	1644
2023 Q2	$2.32M	Buy	+50,000	New	+$1.73M	0.04%	459
2022 Q4	–	Sell	-222,400	Closed	-$4.51M	–	1852
2022 Q3	$4.51M	Buy	+222,400	New	+$4.05M	0.06%	378

Caption Management's DICE Position: Q2 2023 in Review

Caption Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 30,345 shares — an estimated $1.05M sold.

Caption Management first reported a position in DICE in Q4 2022 and held it in 2 quarters. The position peaked at $869K in Q1 2023. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

Caption Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Caption Management sold 30,345 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $1.05M.
Caption Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Caption Management's DICE Therapeutics, Inc. Common Stock position peaked at $869K in Q1 2023.
160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.